Find clinical trials for Pancreatic Cancer in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Warszawa, Mazowieckie, POL:
activity in participants with advanced metastatic colorectal cancer, ovarian cancer, renal cancer or pancreatic c....
Phase 1
Warsaw, Mazowieckie, Poland and 2 other locations
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age....
Phase 1, Phase 2
Warszawa, Poland and 76 other locations
This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors th...
Phase 2
Warszawa, Poland and 122 other locations
The purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer...
Phase 2
Warszawa, Poland and 8 other locations
of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...
Phase 2
Warszawa, Poland and 48 other locations
inhibitor) monotherapy in adult subjects with advanced solid tumors and to identify the maximum tolerated dose (MTD), and the recommended Ph...
Phase 1
Warsaw, Poland and 63 other locations
deruxtecan (T-DXd) for the treatment of selected HER2-expressing tumors.This study will consist of Part 1 which includes 7 cohorts of: uroth ...
Phase 2
Warszawa, Poland and 120 other locations
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory dose response of paltusotine treatment in subjects with c...
Phase 2
Warszawa, Poland and 34 other locations
AFM24-102 is a Phase 1/2a open-label, non-randomized, multicenter, dose escalation, and expansion study evaluating AFM24 in combination with atezoliz...
Phase 1, Phase 2
Warsaw, Poland and 15 other locations
with Everolimus in patients with inoperable, progressive, somatostatin receptor-positive (SSTR+), neuroendocrine tumours of gastroenteric or pancreatic...
Phase 3
Warsaw, Poland and 51 other locations
Clinical trials
Research sites
Resources
Legal